EAGLE Trial CADDIE Artificial Intelligence Endoscopy
EAGLE
Evaluation of Artificial Intelligence for Detection of Gastrointestinal Lesions in Endoscopy (EAGLE)
1 other identifier
interventional
985
5 countries
9
Brief Summary
The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started May 2023
Shorter than P25 for not_applicable colorectal-cancer
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2023
CompletedFirst Posted
Study publicly available on registry
February 15, 2023
CompletedStudy Start
First participant enrolled
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2023
CompletedJuly 3, 2024
July 1, 2024
6 months
January 23, 2023
July 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Adenoma per colonoscopy (APC)
Superiority of CADDIE Arm vs. control.
During the procedure/surgery
Positive percent agreement (PPA)
Non inferiority of CADDIE Arm vs. control.
During the procedure/surgery
Study Arms (2)
CADDIE colonoscopy (CADDIE Arm)
EXPERIMENTALCADDIE is a computer-assisted detection (CADe) device used in conjunction with endoscopy for the detection of abnormal lesions in the gastrointestinal tract.
Standard high-definition white light colonoscopy (Control Arm)
ACTIVE COMPARATORPatients will receive a standard colonoscopy
Interventions
A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.
Eligibility Criteria
You may qualify if:
- Screening or surveillance colonoscopy
- Age 40 years or older
- Informed consent
You may not qualify if:
- Emergency colonoscopies
- Inflammatory bowel disease (IBD)
- Colorectal Cancer (CRC)
- Previous Colorectal Cancer (CRC)
- Previous colonic resection
- Returning for a planned elective therapeutic colonoscopy.
- Polyposis syndromes (familial adenomatous polyposis)
- Contraindication for biopsy or polypectomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odin Medicallead
- Meditrial Europe Ltd.collaborator
Study Sites (9)
Israeli-Georgian Medical Research Clinic Healthycore
Tbilisi, Georgia
Sana Klinikum Lichtenberg
Berlin, Germany
Humanitas Mater Domini
Castellanza, Varese, 21100, Italy
Humanitas Catania
Catania, 95045, Italy
Humanitas Research Hospital
Milan, 20089, Italy
H-T. Centrum Medyczne
Tychy, 43-100, Poland
The Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, 00-001, Poland
Przychodnia Polskiej Fundacji Gastroenterologii
Warsaw, 00-631, Poland
University Hospital "Clinico Lozano Blesa" of Zaragoza
Zaragoza, Spain
Related Publications (1)
Kader R, Hassan C, Lanas A, Romanczyk M, Romanczyk T, Kotowski B, Homedes CS, Mangiavillano B, Bonanno G, Lovat LB, Kaminski M, Faiss S, Repici A. A novel cloud-based artificial intelligence for real-time detection of colorectal neoplasia - a randomized controlled trial (EAGLE). NPJ Digit Med. 2025 Dec 26;9(1):84. doi: 10.1038/s41746-025-02270-1.
PMID: 41449203DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandro Repici, Prof.
Humanitas Research Hospital IRCCS, Rozzano-Milan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Histology of the polyps is performed by the pathologist blinded to the study group assignment.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2023
First Posted
February 15, 2023
Study Start
May 10, 2023
Primary Completion
November 20, 2023
Study Completion
November 29, 2023
Last Updated
July 3, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share